In the present study, while the treatment of KKAy mice with olmesartan did not affect the adipose expression of adiponectin or PPARγ, olmesartan inhibited the adipose tissue gene expression of IL-6, which is also one of the key players in the inflammatory process in adipose tissue in metabolic disorders [22, 31]. The gene discussed is PPARG; the disease is metabolic disease.